Free Trial

N2OFF (NITO) Competitors

N2OFF logo
$0.18 +0.01 (+4.02%)
(As of 12/20/2024 05:31 PM ET)

NITO vs. EVGN, GURE, SNES, CNEY, TANH, GAMCW, LNZAW, ORGNW, PCTTW, and PCTTU

Should you be buying N2OFF stock or one of its competitors? The main competitors of N2OFF include Evogene (EVGN), Gulf Resources (GURE), SenesTech (SNES), CN Energy Group. (CNEY), Tantech (TANH), Golden Arrow Merger (GAMCW), LanzaTech Global (LNZAW), Origin Materials (ORGNW), PureCycle Technologies (PCTTW), and PureCycle Technologies (PCTTU). These companies are all part of the "chemicals" industry.

N2OFF vs.

Evogene (NASDAQ:EVGN) and N2OFF (NASDAQ:NITO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, community ranking, earnings, profitability, valuation and analyst recommendations.

Evogene received 220 more outperform votes than N2OFF when rated by MarketBeat users.

CompanyUnderperformOutperform
EvogeneOutperform Votes
220
55.56%
Underperform Votes
176
44.44%
N2OFFN/AN/A

In the previous week, Evogene had 2 more articles in the media than N2OFF. MarketBeat recorded 2 mentions for Evogene and 0 mentions for N2OFF. Evogene's average media sentiment score of 0.00 equaled N2OFF'saverage media sentiment score.

Company Overall Sentiment
Evogene Neutral
N2OFF Neutral

Evogene presently has a consensus price target of $12.00, indicating a potential upside of 788.89%. Given Evogene's stronger consensus rating and higher probable upside, analysts plainly believe Evogene is more favorable than N2OFF.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evogene
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
N2OFF
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Evogene has a net margin of -314.43% compared to N2OFF's net margin of -3,165.66%. N2OFF's return on equity of -96.06% beat Evogene's return on equity.

Company Net Margins Return on Equity Return on Assets
Evogene-314.43% -109.05% -52.55%
N2OFF -3,165.66%-96.06%-83.65%

N2OFF has lower revenue, but higher earnings than Evogene.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evogene$7.48M0.97-$23.88M-$4.47-0.30
N2OFF$175.31K11.78-$6.52MN/AN/A

10.4% of Evogene shares are owned by institutional investors. Comparatively, 61.2% of N2OFF shares are owned by institutional investors. 7.4% of Evogene shares are owned by insiders. Comparatively, 8.2% of N2OFF shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Evogene has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, N2OFF has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Summary

Evogene beats N2OFF on 9 of the 14 factors compared between the two stocks.

Get N2OFF News Delivered to You Automatically

Sign up to receive the latest news and ratings for NITO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NITO vs. The Competition

MetricN2OFFAgricultural chemicals IndustryStaples SectorNASDAQ Exchange
Market Cap$2.07M$4.40B$14.05B$9.08B
Dividend YieldN/A3.63%2.79%4.23%
P/E RatioN/A40.5021.9617.16
Price / Sales11.783.402.66117.04
Price / CashN/A7.5521.1437.86
Price / Book0.080.845.854.78
Net Income-$6.52M$340.44M$572.90M$225.60M
7 Day Performance-9.00%-11.61%-1.84%-1.23%
1 Month Performance-15.02%-8.16%-3.94%0.46%
1 Year PerformanceN/A-39.14%2.94%15.24%

N2OFF Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NITO
N2OFF
N/A$0.18
+4.0%
N/AN/A$2.07M$175,308.000.002Gap Up
High Trading Volume
EVGN
Evogene
2.1582 of 5 stars
$1.32
-3.6%
$12.00
+809.1%
-84.0%$7.08M$7.48M-0.31140Analyst Forecast
Positive News
GURE
Gulf Resources
N/A$0.65
+4.8%
N/A-55.7%$6.97M$12.80M-0.07380
SNES
SenesTech
2.5218 of 5 stars
$3.54
-10.2%
$10.00
+182.5%
-61.4%$3.65M$1.19M0.0030Analyst Forecast
News Coverage
Gap Up
High Trading Volume
CNEY
CN Energy Group.
0.4369 of 5 stars
$0.29
-11.0%
N/A-85.5%$1.97M$66.51M0.0030
TANH
Tantech
0.6306 of 5 stars
$0.15
+2.2%
N/A-85.3%$580,000.00$47.32M0.0070Positive News
Gap Up
High Trading Volume
GAMCW
Golden Arrow Merger
N/A$0.03
flat
N/A-83.3%$0.00N/A0.001
LNZAW
LanzaTech Global
N/A$0.10
+17.6%
N/A-82.9%$0.00$58.03M0.003Positive News
ORGNW
Origin Materials
N/A$0.09
-14.2%
N/A+80.7%$0.00$35.12M0.00160Positive News
Gap Up
PCTTW
PureCycle Technologies
N/A$4.25
-0.7%
N/A+231.8%$0.00N/A0.00120Positive News
PCTTU
PureCycle Technologies
N/A$15.72
-1.0%
N/A+208.2%$0.00N/A0.00120Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:NITO) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners